DRDATSONS

Kannan Vishwanath has submitted to the Exchange vide its letter dated September 27, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for acquisition of 7250 shares.

Kannan Vishwanath has submitted to the Exchange vide letter dated September 29, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for acquisition of 2000 shares.

Aanjaneya Lifecare Limited has informed the Exchange vide letter dated September 24, 2012, regarding "Prestigious "BSE AWARD for BEST RETURN TO INVESTORS 2012".

Aanjaneya Lifecare Limited has informed the Exchange regarding the Outcome of Annual General Meeting of the Shareholders of the Company held on September 10, 2012.

Kannan Vishwanath has submitted to the Exchange vide letter dated September 05, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated September 05, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 .

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated September 04, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Kannan Vishwanath has submitted to the Exchange vide letter dated August 30, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated August 29, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 alongwith a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Kannan Vishwanath has submitted to the Exchange vide letter dated August 27, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Kannan Vishwanath has submitted to the Exchange vide letter dated August 22, 2012 a copy of disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated August 21, 2012 a copy of disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Kannan Vishwanth has submitted to the Exchange vide letter dated August 17, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated August 14, 2012 a copy of disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated August 13, 2012, titled "Excellent Performance by Anjaneya Lifecare Limited as total Q1 income jumps by 74% and PAT shot up by 68%".

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 13, 2012 has decided to finalise the modalities to open branch offices outside India i.e. in Uganda, Tanzania, Dubai and Singapore.

Aanjaneya Lifecare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30, 2012.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated August 06, 2012 a copy of disclosure under Regulation 31(1) and 31(1) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Dr. Kannan Vishwanth has submitted to the Exchange vide letter dated August 03, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated July 31, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated July 26, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 alongwith a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Kannan Vishwanath has submitted to the Exchange vide letter dated July 28, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 alongwith a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Kannan Vishwanath has submitted to the Exchange vide letter dated July 26, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 alongwith a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange, vide letter dated July 27, 2012, a copy of Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated July 23, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 alongwith a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Kannan Vishwanath has submitted to the Exchange, vide letter dated July 11, 2012 a copy of Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated July 12, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated July 10, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Religare Finvest Limited has submitted to the Exchange vide letter dated July 09, 2012 a copy of Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated July 02, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 30, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 26, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Religare Finvest Limited has submitted to the Exchange vide letter dated June 25, 2012 a copy of Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 22, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated June 20, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated June 19, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 18, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations,1992.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 15, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 14, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations,1992.

Finaventure Capital Limited has submitted to the Exchange a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 07, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations,1992.

Kannan Vishwanath has submitted to the Exchange vide its letter dated June 08, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Aanjaneya Lifecare Limited has informed the Exchange that Mr. Minhaj Khan is appointed as the Non executive Independent Director of the Company w.e.f. June 11, 2012.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated June 06, 2012, a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure under Regulation 13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations,1992.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated May 31, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2012, have recommended a Dividend, subject to the approval of shareholders in the ensuing Annual General Meeting of the Company @ 20% on 1,38,87,151 Equity Shares of the Rs. 10/- each (i.e. Rs. 2/- per Equity Share).

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated May 30, 2012, titled "Aanjaneya Lifecare Limited total income jumps by 50% in FY11-12, Declares Rs.2 dividend".

Aanjaneya Lifecare Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2012.

Religare Finvest Limited has submitted to the Exchange, vide letter dated May 21, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company has decided to nominate Mr. Kashi Vishwanathan as Chairman Emeritus of the Company and who shall not be a Board Member.